Matrix Capital Management Company, LP Adaptimmune Therapeutics PLC Transaction History
Matrix Capital Management Company, LP
- $10.8 Billion
- Q1 2024
A detailed history of Matrix Capital Management Company, LP transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Matrix Capital Management Company, LP holds 38,974,185 shares of ADAP stock, worth $38.2 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
38,974,185
Previous 38,974,185
-0.0%
Holding current value
$38.2 Million
Previous $30.8 Million
100.0%
% of portfolio
0.57%
Previous 0.32%
Shares
9 transactions
Others Institutions Holding ADAP
# of Institutions
84Shares Held
160MCall Options Held
42.8KPut Options Held
42.1K-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$26.9 Million1.23% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$16.7 Million1.89% of portfolio
-
Baillie Gifford & CO15.9MShares$15.6 Million0.02% of portfolio
-
Baker Bros. Advisors LP New York, NY10.8MShares$10.6 Million0.22% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.7MShares$10.5 Million0.91% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $160M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...